These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11985559)

  • 21. Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study.
    Chou DS; Hsiao G; Shen MY; Fong TH; Lin CH; Chen TF; Sheu JR
    Lipids; 2004 May; 39(5):433-40. PubMed ID: 15506238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
    Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
    Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
    Touyz RM; Schiffrin EL
    J Hypertens; 1994 Nov; 12(11):1255-63. PubMed ID: 7868873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
    Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS
    Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Na+/H+ exchange modulates Ca2+ mobilization in human platelets stimulated by ADP and the thromboxane mimetic U 46619.
    Siffert W; Siffert G; Scheid P; Akkerman JW
    J Biol Chem; 1990 Jan; 265(2):719-25. PubMed ID: 2153112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
    Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of aggregation of platelets in pregnancy-induced hypertension: a comprehensive and longitudinal study.
    Lin KC; Chou TC; Yin CS; Ding YA
    Int J Cardiol; 1991 Oct; 33(1):125-31. PubMed ID: 1937968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation.
    Wu TM; Li ML; Chou TC
    Thromb Res; 2000 Feb; 97(4):191-9. PubMed ID: 10674405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in platelet concentration and aggregation in normal pregnancy and preeclampsia.
    O'Brien WF; Saba HI; Knuppel RA; Scerbo JC; Cohen GR
    Am J Obstet Gynecol; 1986 Sep; 155(3):486-90. PubMed ID: 3752171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of anagrelide on platelet cAMP levels, cAMP-dependent protein kinase and thrombin-induced Ca++ fluxes.
    Seiler S; Arnold AJ; Grove RI; Fifer CA; Keely SL; Stanton HC
    J Pharmacol Exp Ther; 1987 Nov; 243(2):767-74. PubMed ID: 2824759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304), an antithrombotic agent.
    Zhang YH; Chung KH; Ryu CK; Lee YH; Kim TJ; Song YS; Hwang KA; Yun YP
    Pharmacol Toxicol; 2001 Apr; 88(4):181-6. PubMed ID: 11322175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
    Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
    Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension.
    Liel N; Nathan I; Yermiyahu T; Zolotov Z; Lieberman JR; Dvilansky A; Halushka PV
    Thromb Res; 1993 May; 70(3):205-10. PubMed ID: 8327985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.